dup 697 has been researched along with celecoxib in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baurin, N; Chavatte, P; Lesieur, D; Marot, C; Yous, S | 1 |
| Amini, M; Amirhamzeh, A; Assadieskandar, A; Ostad, SN; Ozadali, K; Salehi, M; Shafiee, A | 1 |
| Alfonso, S; Anzini, M; Biava, M; Consalvi, S; Di Capua, A; Di Cesare Mannelli, L; Ghelardini, C; La Motta, C; Pirolli, A; Poce, G; Ragno, R; Sabatino, M; Sartini, S | 1 |
| Chaturbhuj, GU; Goyal, SN; Indalkar, KS; Khatri, CK; Patil, CR | 1 |
| Ramajayam, R | 1 |
| Chung, HY; Hong, J; Ju, Z; Jung, JH; Kim, S; La Kim, E; Moon, HR; Su, M | 1 |
| McKnight, W; Reuter, BK; Vergnolle, N; Wallace, JL | 1 |
| Chen, C; Hsu, A; Johnson, AJ; song, X | 1 |
1 review(s) available for dup 697 and celecoxib
| Article | Year |
|---|---|
Medicinal chemistry of vicinal diaryl scaffold: A mini review.
Topics: Carbonic Anhydrase IV; Chemistry, Pharmaceutical; Cyclooxygenase 2 Inhibitors; Drug Discovery; Humans; Hydrocarbons, Aromatic; Structure-Activity Relationship | 2019 |
7 other study(ies) available for dup 697 and celecoxib
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: a comparative molecular field analysis.
Topics: Benzene Derivatives; Binding Sites; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cyclopentanes; Imidazoles; Isoenzymes; Isoxazoles; Models, Molecular; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Pyrroles; Quantitative Structure-Activity Relationship; Spiro Compounds; Thiophenes | 2001 |
Synthesis, cyclooxygenase inhibitory effects, and molecular modeling study of 4-aryl-5-(4-(methylsulfonyl)phenyl)-2-alkylthio and -2-alkylsulfonyl-1H-imidazole derivatives.
Topics: Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Humans; Imidazoles; Models, Molecular; Structure-Activity Relationship | 2013 |
Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors.
Topics: Acetamides; Acetates; Analgesics; Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Design; Humans; Methylation; Mice; Molecular Docking Simulation; Rats, Sprague-Dawley; Rats, Wistar; Structure-Activity Relationship; Sulfur Compounds | 2015 |
Novel 2-phenyl-4,5,6,7-tetrahydro[b]benzothiophene analogues as selective COX-2 inhibitors: Design, synthesis, anti-inflammatory evaluation, and molecular docking studies.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase 2 Inhibitors; Drug Design; Edema; Mice; Molecular Docking Simulation; Rats; RAW 264.7 Cells; Thiophenes | 2017 |
Design of balanced COX inhibitors based on anti-inflammatory and/or COX-2 inhibitory ascidian metabolites.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Design; Humans; Mice; Models, Molecular; Molecular Structure; RAW 264.7 Cells; Sheep; Structure-Activity Relationship; Urochordata | 2019 |
NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cell Adhesion; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Gastric Mucosa; Isoenzymes; Ketorolac; Leukocytes; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrazoles; Rats; Rats, Wistar; Regional Blood Flow; Stomach; Sulfonamides; Thiophenes | 2000 |
Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells.
Topics: Apoptosis; Calcium; Celecoxib; Cell Cycle; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Humans; Isoenzymes; Lactones; Male; Membrane Proteins; Models, Chemical; Nitrobenzenes; Phosphatidylinositol 3-Kinases; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Signal Transduction; Sulfonamides; Sulfones; Thiophenes; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |